For this reason, we developed the strategy of using restriction fragment length polymorphisms (RFLPs) that are associated with random probes throughout the genome to map the MS locus. We present the results of our analysis of 10 three generation families here.
Marfan syndrome (MS) is an autosomal dominant disorder of the connective tissue, characterised by cardiovascular, musculoskeletal, ocular, and pulmonary abnormalities. This condition is estimated to have a prevalence of 4 to 6 per 100 000 persons and imparts significant morbidity and mortality.' 2 Although the clinical manifestations of this disorder have been very Table 2 summarises the structure of the 10 pedigrees initially collected for this study.
The power of a linkage study using these families was then determined using the programs SIMLINK and LODSTAT.l9 Simulation using a two allele system with frequencies of 0-6 and 0-4 (heterozygosity=0 48) identified four families that would each yield a mean maximum lod score of less than 1-0 when the true recombination fraction was zero. In addition, these same families each had a mean estimated probability of greater than 0 5 of having a lod score greater than 0 0 at 0 = 0 1 when the marker was actually unlinked. These four families were removed from further analyses and the power of the remaining six families was estimated. Under the same conditions as above, a lod score of 3-0 or greater should be obtained over 90% of the time when the true recombination fraction is 0-05 and 70% of the time when the true recombination fraction is 0-1. Moreover, with these six families an unlinked marker will generally be excluded for a recombination fraction of 0-18. For those marker loci having heterozygosities greater than 0.48, the distance at which linkage can be established or can be ruled out will be greater than the above estimates. These 
Results
All probes used gave informative results in at least one family. The approximate chromosomal location is known for all of these probes. Eight of these families were also typed for the Rh blood group. None of the marker loci was linked to the MS locus at 0=0 0. At 0=0 1, 26 out of the 40 loci had a lod score of -2-0 or less. Linkage could be ruled out at 0=0 05 for an additional four loci. Linkage of MS to various markers in the region surrounding the Rh locus was 
